Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K190277
    Date Cleared
    2019-07-08

    (150 days)

    Product Code
    Regulation Number
    884.3575
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    ProVate Vaginal Support

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The ProVate Vaginal Support is indicated for the temporary, nonsurgical management of Pelvic Organ Prolapse in females.

    Device Description

    The ProVate Vaginal Support is a vaginal ring pessary intended for the conservative nonsurgical, temporary management of Pelvic Organ Prolapse (POP) in females. The ProVate is a disposable, single use device intended to use for up to seven (7) days. The ProVate device is intended for prescription home use following a size fitting process performed by a health care professional. The device is supplied in its compact mode, within a disposable Applicator intended for the insertion of the device is expanded into its circular ring shape using the Applicator Plunger when inserting the device into the vagina. At the end of its use (up to 7 days), the patient pulls the Removal String which collapses the device into its compact configuration, facilitating easy removal. The device is then thrown away, and a new device can be inserted by the patient as needed. The ProVate includes additional components to facilitate insertion and removal of the device. The ProVate device is constructed to allow insertion into the vagina by the patient while the device is in a compact mode contained within a single use applicator. The ProVate device is expanded to its circular shape using the applicator when inserted into the vagina. Once inserted, the circular shape of the ProVate is comparable to that of the predicate device and the ring provides support to the prolapsed organs. To remove the device, the ProVate includes a removal string. Pulling on the string collapses the device to its compact state allowing for easier and more comfortable removal.

    AI/ML Overview

    The ConTIPI Medical Ltd. ProVate Vaginal Support is a vaginal pessary intended for the temporary, nonsurgical management of Pelvic Organ Prolapse (POP) in females. The device's safety and effectiveness were evaluated through a series of bench tests and two clinical studies.

    1. Acceptance Criteria and Reported Device Performance

    The provided document does not explicitly present a table of "acceptance criteria" against which specific device performance metrics are directly reported in a comparative format. However, the document outlines various tests conducted and their successful outcomes, indicating that the device met the performance and safety requirements. The performance data section provides indirect evidence of fulfilling acceptance criteria.

    Test CategorySpecific Test / CriterionReported Device Performance
    Bench TestingInsertion ForceMet key performance specifications
    Removal ForceMet key performance specifications
    Directional compressionMet key performance specifications
    Repeatable directional compressionMet key performance specifications
    Extreme compressionMet key performance specifications
    Load on central AxisMet key performance specifications
    String Detachment ForceMet key performance specifications
    Removal String IntegrityMet key performance specifications
    Shelf LifeShelf life of the productSupported two (2) years shelf life
    BiocompatibilityCytotoxicity Study (ISO 10993-5)Non-cytotoxic
    Guinea Pig Maximization Sensitization Test (ISO 10993-10)Non-sensitizer
    Vaginal Irritation Study in Rabbits (ISO 10993-10)Non-irritant
    Muscle Implantation Study in Rabbits (ISO 10993-6)Macroscopic: Difference not significant; Microscopic: Non-irritant
    Genotoxicity: Bacterial Reverse Mutation Study (ISO 10993-3)Non-mutagenic
    Genotoxicity: Mouse Lymphoma Assay (ISO 10993-3)Non-mutagenic
    Toxicological Risk assessment (ISO 10993-18)Acceptable risk of daily dose-exposure to compounds from device use
    Microflora ImpactEvaluation of TSST-1 RiskLaboratory testing to evaluate impact on Staphylococcus aureus growth and TSST-1 production was performed (results not explicitly stated as metric, but implies acceptable risk)
    Clinical Study 1Primary endpoint: Changes in vaginal microflora (non-inferiority to control)Met successfully, showing non-inferiority of ProVate Device
    Clinical Study 2Improvement in prolapse from baseline (at least one stage)Demonstrated improvement from baseline of at least one stage in prolapse while in use
    Improvement in prolapse symptomsDemonstrated improvement in prolapse symptoms
    Safety: Adverse events rateDid not result in adverse events at a higher rate than predicate pessary devices; all device-related adverse events were mild and transient

    2. Sample Sizes and Data Provenance

    The document describes two clinical studies:

    • Prospective Safety Clinical Study:
      • Sample Size: Not explicitly stated but described as "statistically powered."
      • Data Provenance: Multicenter, randomized, cross-over study. The country of origin is not explicitly stated, but the manufacturer is based in Israel and the submission is to the U.S. FDA, suggesting potential international or U.S.-based study sites. The study design is prospective.
    • Prospective Clinical Study to Evaluate Safety and Effectiveness:
      • Sample Size: Not explicitly stated but described as "statistically powered."
      • Data Provenance: One arm, multi-clinic prospective study. Country of origin not explicitly stated.

    3. Number of Experts and Qualifications (for Ground Truth)

    The document does not detail the number of experts or their specific qualifications for establishing ground truth within the clinical studies. For the clinical studies, vaginal examinations were conducted by physicians, who would serve as experts in assessing prolapse stages and adverse events. Specific qualifications (e.g., years of experience, specialization) are not provided.

    • In the "Prospective Clinical Study to Evaluate Safety and Effectiveness," a "fitting process performed by a physician" is mentioned, indicating the involvement of medical professionals in determining appropriate device sizing and assessment.
    • "Vaginal examinations and microbial evaluations were performed at the beginning and at the end of each usage phase" in the safety study, again implying medical expert assessment.

    4. Adjudication Method

    The document does not specify an adjudication method for the test set data (e.g., 2+1, 3+1 for resolving discrepancies). It is implied that clinical assessments were made by individual clinicians or study investigators.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    No Multi-Reader Multi-Case (MRMC) comparative effectiveness study is mentioned. The clinical studies focused on the performance of the device itself, either in comparison to a control device (for microflora) or against a baseline (for prolapse improvement), rather than on the impact of AI assistance on human readers.

    6. Standalone Performance Study (Algorithm Only)

    This device is a physical medical device (vaginal pessary), not a software or AI algorithm. Therefore, a standalone (algorithm only) performance study is not applicable and was not conducted.

    7. Type of Ground Truth Used

    The ground truth for the clinical studies was based on:

    • Clinical Assessments: Vaginal examinations performed by physicians to assess prolapse stage (e.g., improvement by at least one stage, starting from stage 2 or 3 to stage 0 or 1).
    • Microbial Evaluations: Laboratory analysis of vaginal microflora.
    • Adverse Event Reporting: Clinical evaluation and reporting of adverse events.

    This constitutes a combination of expert clinical assessment and laboratory data.

    8. Sample Size for the Training Set

    This question is not applicable. The ProVate Vaginal Support is a physical medical device, not an AI or machine learning model that requires a training set. The "training" in this context refers to the development and iterative testing of the device, which is informed by engineering principles, bench testing, and clinical feedback, rather than a data training set for an algorithm.

    9. How Ground Truth for the Training Set was Established

    This question is not applicable for the same reason as point 8. The device development process involves engineering specifications and preclinical/clinical data gathering, not the establishment of ground truth for an algorithmic training set.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1